Advertisement

News Stories

Nov, 2018

Nov. 10, 2018

CHICAGO The REDUCE-IT cardiovascular outcomes trial results, announced today at the American Heart Association Scientific Sessions in Chicago, met its primary composite endpoint and revealed a reduction in major adverse cardiovascular events (MACE) of 25%.

Download the manuscript online now.

0
No votes yet
Name: Members in the News
Nov, 2018

Nov. 10, 2018

NLA among 12 organizations to co-author, endorse key document for reducing risk of atherosclerotic cardiovascular disease

0
No votes yet
Name: NLA News

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service